CA9 and nonpapillary renal cell carcinoma: IMPLICATIONS FOR PATIENT CARE: CAIX is aberrantly expressed in more than 90% of ccRCC cases, and current diagnostic methods using radiolabeled anti-CAIX antibodies take several days to visualize tumors.